Inhibition of the protein kinase CK2 prevents the development of auto-aggressive T cells, say multiple sclerosis researchers. Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system.
Inhibition of the protein kinase CK2 prevents the development of auto-aggressive T cells, say multiple sclerosis researchers. Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system.